Canada markets closed

JNJ Jan 2025 165.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
18.20+0.07 (+0.39%)
As of 02:13PM EST. Market open.
Full screen
Previous Close18.13
Expire Date2025-01-17
Day's Range17.25 - 18.20
Contract RangeN/A
Open Interest250
  • Yahoo Finance

    COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst

    Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.

  • Reuters

    COLUMN-3M foes act fast to capitalize on J&J’s talc bankruptcy defeat

    When a U.S. appeals court ruled on Monday that Johnson & Johnson can’t use the U.S. bankruptcy system to offload vast litigation exposure from product liability claims, the people who reacted most quickly were undoubtedly J&J investors. Within hours of the 3rd U.S. Circuit Court of Appeals decision, investors drove J&J’s share price down by nearly 4% -- its biggest one-day decline in years. But another, albeit much smaller, group of people was also roiled by Monday’s ruling from the 3rd Circuit: appellate lawyers who were finishing up friend-of-the-court briefs due on Wednesday in a 7th Circuit appeal by 3M Co that presents issues similar to those in the J&J case.

  • Business Wire

    Johnson & Johnson to Participate in the Cowen 43rd Annual HealthCare Conference

    NEW BRUNSWICK, N.J., February 02, 2023--Johnson & Johnson (NYSE: JNJ) will participate in the Cowen 43rd Annual HealthCare Conference on Tuesday, March 7th, at the Boston Marriott Copley Place, Boston, MA. Joseph J. Wolk, Executive Vice President and Chief Financial Officer will represent the Company in a session scheduled at 11:10 a.m. (Eastern Time).